Pharmaceutical Grade Lactose Market to Register approx. 4.1% CAGR during 2017-2023

Pune, India, October, 2018 /press release/- Market Research Future Published a Cooked Research Report on Pharmaceutical Grade Lactose Market Research Report

Pharmaceutical grade lactose, crystalline white (milk) powder with a slightly sweet taste is a disaccharide, comprised of galactose and glucose. This lactose is commonly used as an excipient, as a filler or binder in the pharmaceutical industry.

The pharmaceutical grade lactose is also extensively used as a source of low-glycemic index carbohydrate, low sweetening power, and calorific value in nutrition, infant formula, healthcare, food, beverages, feed, and in cell culture supplements.

As a result, pharmaceutical grade lactose perceives a massive demand across its end-user industries which drives its market growth and increases its market size. Commodities from pharma lactose are expected to witness increased growth which will define the market landscape in the years to come.

Acknowledging the increasing size of the market, Market Research Future (MRFR) in its recently published study report asserts that the global pharmaceutical grade lactose market will register approximately 4.1% CAGR during the forecast period (2017-2023).

Increasing demand for dry powder inhalers (DPI) products, high compatibility with active pharmaceutical ingredients (APIs), and the emergence of nanotechnology that has enhanced the production quality of pharmaceutical grade lactose are the key factors spurring the market growth.

Due to the dietary fiber, pre-biotic properties, pharmaceutical lactose is hugely consumed by the dietary supplements, probiotics, energy drinks, and milk beverages, which is a key driving force behind the substantial market demand this product witnesses.

New product development using pharma lactose is expected to increase the commercialization of the product, driving the demand for lactose in the near future. Additional factors substantiating the market growth include changing lifestyle and the growing per capita income that has led to changing consumers’ food preferences.

This encourages manufacturers in the F&B sector to develop innovative products, to cater to the changing preferences which, in turn, drive the market growth of pharmaceutical lactose.

Access Report @ https://www.marketresearchfuture.com/reports/pharmaceutical-grade-lactose-market-4816

Global Pharmaceutical Grade Lactose Market – Segments

MRFR has segmented its analysis into three key dynamics for an easy grasp;

By Types                   : Crystalline Monohydrate Lactose (α-Lactose and β-Lactose), Inhalation Lactose (milled and sieved.), Granulated Lactose, and Spray Dried Lactose among others.

By Applications     : Tablets manufacturing (direct compression, wet granulation, and dry granulation and others.) and Capsule manufacturing (capsules, sachets, and others.) among others.

By Regions              : North America, Europe, APAC and the Rest-of-the-World.

Global Pharmaceutical Grade Lactose Market –

Regional Analysis

The European region accounts for the leading market for pharmaceutical grade lactose, mainly due to its significant dairy markets. With the dairy commodity becoming more global, the pharmaceutical grade lactose market in the region is attracting many national and multinational companies towards Europe.  With 60% of the market share, Europe holds a firm grip on the global market, and that is expected to remain tight throughout the next six years as well. Countries fetching the maximum revenue are Germany, France, the U.K., Italy, and Spain.

With the resurging economy in the region, healthcare expenditures too are witnessing a significant surge which subsequently has spurred an increase in the research and development activities in the pharmaceutical industries which has a direct impact on the market growth. The western European region is dominating the regional market in terms of accruals of revenues which are expected to grow from USD 56.247 MN to USD 75.089 MN over the forecast period whereas; the Eastern European region is expected to grow at 4.5% CAGR through the forecast period.

The Asia Pacific region is another lucrative market for pharmaceutical grade lactose, globally.  Due to the burgeoning pharma sector, the region is expected to witness a spurting growth over the projected period. Furthermore, availability of cost-competitive logistic required for the production of pharmaceutical lactose, such as land, feedstock, and the labour force in the region attracts foreign investors and encourages multinational companies to shift their production bases in the developing economies such India, and China, which in turn,  foster the market growth in the APAC.

On the other hand, pharmaceutical grade lactose market in the North American region is witnessing an upsurge mainly due to the rapidly growing industries such as pharmaceutical, nutrition, healthcare, food, infant formula, and feed among others. The North American region is well-developed with the highest GDP in the world; this certainly gives it an edge over other regions in terms of lifestyle, medications and medical technology. Due to the highest healthcare expenditures, the region has a well-established healthcare sector providing the best drugs and quality care which drives the market for pharmaceutical grade lactose in the region.

Global Pharmaceutical Grade Lactose Market – Competitive Analysis

Manufacturers bank on collaborating and forming partnerships with other players to develop new manufacturing methods and innovations. The market appears to be fragmented and highly competitive with the presence of several big and small players. Key players focus on optimized situational awareness to ensure their mission success.

Manufacturers of pharmaceutical grade lactose use a variety of particle size distributions and appropriate modifications to ensure consistently high quality and consistency between batches of product. By using precision monitoring they ensure justified consumer and business confidence in the premium quality of the products are being manufactured.

They increasingly invest in R&D activities; possess state of the art labs and production units, strong sales and distribution network while focusing on inbound lead generation, looking for ROI-oriented strategies. 

Key Players:

Some of the eminent leaders of the market include Merck KGaA (Germany), Meggle (Germany), Kerry Inc. (Ireland), DFE Pharma (Germany), Armor Pharma (France), ALPAVIT (Germany), and BASF Corporation (Germany).

Industry/ Innovation/ Related News:

October 17, 2018 – Kerry Biofunctional Ingredients, Inc (US), a leading global producer and distributor of food and beverage ingredients, announced the acquisition of pharmaceutical lactose business of Foremost Farms (US) to compete in the pharmaceutical business strategically.

Both companies decided that the manufacturing and marketing of these products need to be combined under single ownership to remain competitive in today’s rapidly-changing environment. Together both companies believe this will be the best way to drive profitability and growth in this marketplace while still protecting the interests of both companies into the future.